The effect of cholestasis and neuroAID treatment on Bcl-xl gene expression in hippocampus of male rats

Authors

Abstract

Background and Objective: Cholestasis is bile duct obstruction with accumulation of toxic bile acids in liver and circulatory systems and increased toxicity in hepatocytes. Some studies have shown that cholestasis induces spatial memory deficit. Hippocampus plays an important role in this process. In this research, the effect of cholestasis on expression of BCL-XL (B-cell lymphoma-extra large as genes in apoptosis further) in hippocampus of male rat was assessed. Moreover, the preventive effect of neuroAID (MLC901) on above-mentioned changes regarding gene expression was also evaluated.
 
Materials and Methods: This project was done on 16 rats weighing 220-240 g, which were divided into three main groups including control, sham and BDL (Bile Duct Ligation). Thereafter, hippocampus region was extracted and the expression level of genes were assessment by Real-Time PCR. Results were analyzed using one-way ANOVA followed by a Tukey test. Significant level was 0.05.
 
Results: The results of sham-NeuroAID & BDL-NeuroAID groups indicate that NeuroAID significantly increases the expression level of Bcl-Xl gene in comparison with control group. In addition, there was no significant change for subsequent effect of cholestasis in the expression level of Bcl-Xl gene in BDL group.
 
Conclusion: Results of the current study indicates that NeuroAID can alter negative effect of cholestasis by decreasing apoptosis phenomenon.
 

Keywords

References

1. Shaffer EA. Cholestasis: the ABCs of Cellular mechanisms for impaired bile secretion-transporters and genes. Canadian Journal of Gastroenterology 2002;16(6):380-9. 2. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Journal of Hepatology 1991;14(3):551-66. 3. Keely SJ, Scharl MM, Bertelsen LS, Hagey LR, Barrett KE, Hofmann AF. Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure-activity relationships. American Journal of Physiology Gastrointestinal and Liver Physiology 2007;292(1):G290-7. 4. Wagner M, Zollner G, Trauner M. New Molecular insights into the mechanisms of cholestasis. Journal of Hepatology 2009;51(3):565-80. 5. Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. The New England Journal of Medicine 1998;339(17):1217-27. 6. Khalaf R, Phen C, Karjoo S, Wilsey M. Cholestasis beyond the neonatal and infancy periods. Pediatric Gastroenterology, Hepatology & Nutrition 2016;19(1):1-11. 7. Thompson CB.Apoptosis in the pathogenesis and treatment of disease. Science 1995;267(5203):1456-62. 8. Thorburn A. Death receptor-induced cell killing. Cellular Signalling. 2004;16(2):139-44. 9. Korsmeyer SJ. Regulators of cell death. Trends in Genetics:1995;11(3):101-5. 10. Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Seminars in Liver Disease 1998;18(2):105-14. 11. Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World Journal of Gastroenterology 2006;12(28):4445-51. 12. Quintard H, Lorivel T, Gandin C, Lazdunski M, Heurteaux C. MLC901, a Traditional Chinese Medicine induces neuroprotective and neuroregenerative benefits after traumatic brain injury in rats. Neuroscience 2014;277:72-86. 13. Heurteaux C, Gandin C, Borsotto M, Widmann C, Brau F, Lhuillier M, et al. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese Medicine, in vitro and in vivo. Neuropharmacology 2010;58(7):987-1001. 14. Ernst A, Alkass K, Bernard S, Salehpour M, Perl S, Tisdale J, et al. Neurogenesis in the striatum of the adult human brain. Cell 2014;156(5):1072-83. 15. Kempermann G, Song H, Gage FH. Neurogenesis in the adult hippocampus. Cold Spring Harbor Perspectives in Biology 2015;7(9):a018812. 16. Quintard H, Borsotto M, Veyssiere J, Gandin C, Labbal F, Widmann C, et al. MLC901, a Traditional Chinese Medicine protects the brain against global ischemia. Neuropharmacology 2011;61(4):622-31. 17. Reza Zarrindast M, Eslimi Esfahani D, Oryan S, Nasehi M, Torabi Nami M. Effects of dopamine receptora gonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. European Journal of Pharmacology 2013;702. 18. Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. The American Journal of Gastroenterology 2004;127(1):261-74. 19. Reinehr R, Becker S, Keitel V, Eberle A, Grether-Beck S, Haussinger D. Bile salt-induced apoptosis involves NADPH oxidase isoform activation. The American Journal of Gastroenterology 2005; 129:2009-2031 20. Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. Journal of Hepatology 2002; 37: 400-410 21. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A Novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. Journal of Clinical Investigation 1998; 101: 2790-2799 22. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Molecular Medicine 1998; 4: 165-178.
Daneshvar Medicine
Volume 25, Issue 5 - Serial Number 132
November and December 2017
Pages 7-14

Files

Share

How to cite

Statistics